Grant: Research Tools and Instruments - Category 1 (<$150,000)
University of Western Ontario
$150,000.00
Extracellular flux analyzer to accurately monitor the real-time kinetics of cellular and mitochondrial bioenergetics
EF 2014-15
Résumé
This application seeks funds to purchase a Seahorse XFe24 Extracellular Flux Analyzer, a state of the art instrument capable of simultaneously measuring multiple metabolic parameters within intact cells or isolated mitochondria in a high throughput 24-well format. We will use this instrument to study the metabolic pathways used by all cells to produce and consume energy. Such analyses are essential for several research areas in both fundamental biology and clinical science research at Western. The Seahorse XFe Analyzer permits simultaneous, real-time assessment of mitochondrial respiration and cellular glycolysis, by measuring oxygen consumption and extracellular acidification rates in intact live cells. This state-of-the-art instrument is not currently available to Western researchers. Instead we rely on dated, low throughput and time-consuming techniques to assess these biological processes, so our research productivity is limited. Traditionally, measurements of oxygen consumption have been undertaken using polarographic (Clark-type) or fiber optic (e.g. Ocean Optics) oxygen electrode systems, which can only read one or two samples at a time and, at Western, practical use of these systems is seriously limited due to their low throughput. The Seahorse system has an advantage over these conventional systems by being amenable to experiments on adherent cells, as well as cell suspensions or subcellular components, allowing use of physiologically relevant models. Moreover, the technology requires fewer cells for measuring oxygen consumption rates, and cells remain viable following analysis for use in subsequent experiments or assays. The Seahorse system also comes with four compound injection ports enabling programmed sequential addition of modulators for energy pathway interrogation, dose-response, or agonist-antagonist analyses. The Seahorse XFe Analyzer is critical for Western researchers to conduct high throughput, accurate, mechanistic investigations of cellular energy metabolism and to train the next generation of scientists in cutting edge cellular and mitochondrial bioenergetics to integrate metabolic profiling with their functional genomic and proteomic data.
Programme
Research Tools and Instruments - Category 1 (<$150,000)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
472917-2015
Name nom
Betts, Dean
Department département
Physiology and Pharmacology
Organization id
36
Institution établissement
University of Western Ontario
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2015
Award amount
150000
Program id
EQPEQ
Program name en
Research Tools and Instruments - Category 1 (<$150,000)
Program name fr
Outils et instruments de recherche - catégorie 1 (<150 000$)
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Partie
1
Nb partie
1
Application title
Extracellular flux analyzer to accurately monitor the real-time kinetics of cellular and mitochondrial bioenergetics
Keyword
NSERC
Application summary
This application seeks funds to purchase a Seahorse XFe24 Extracellular Flux Analyzer, a state of the art instrument capable of simultaneously measuring multiple metabolic parameters within intact cells or isolated mitochondria in a high throughput 24-well format. We will use this instrument to study the metabolic pathways used by all cells to produce and consume energy. Such analyses are essential for several research areas in both fundamental biology and clinical science research at Western. The Seahorse XFe Analyzer permits simultaneous, real-time assessment of mitochondrial respiration and cellular glycolysis, by measuring oxygen consumption and extracellular acidification rates in intact live cells. This state-of-the-art instrument is not currently available to Western researchers. Instead we rely on dated, low throughput and time-consuming techniques to assess these biological processes, so our research productivity is limited. Traditionally, measurements of oxygen consumption have been undertaken using polarographic (Clark-type) or fiber optic (e.g. Ocean Optics) oxygen electrode systems, which can only read one or two samples at a time and, at Western, practical use of these systems is seriously limited due to their low throughput. The Seahorse system has an advantage over these conventional systems by being amenable to experiments on adherent cells, as well as cell suspensions or subcellular components, allowing use of physiologically relevant models. Moreover, the technology requires fewer cells for measuring oxygen consumption rates, and cells remain viable following analysis for use in subsequent experiments or assays. The Seahorse system also comes with four compound injection ports enabling programmed sequential addition of modulators for energy pathway interrogation, dose-response, or agonist-antagonist analyses. The Seahorse XFe Analyzer is critical for Western researchers to conduct high throughput, accurate, mechanistic investigations of cellular energy metabolism and to train the next generation of scientists in cutting edge cellular and mitochondrial bioenergetics to integrate metabolic profiling with their functional genomic and proteomic data.